z-logo
open-access-imgOpen Access
Utility of p63 immunohistochemical stain in differentiating urothelial carcinomas from adenocarcinomas of prostate
Author(s) -
Nasir Ud Din,
Asim Qureshi,
Samina Mansoor
Publication year - 2011
Publication title -
indian journal of pathology and microbiology/indian journal of pathology and microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.217
H-Index - 31
eISSN - 0974-5130
pISSN - 0377-4929
DOI - 10.4103/0377-4929.77326
Subject(s) - medicine , adenocarcinoma , immunohistochemistry , prostate , pathology , carcinoma , stain , urinary bladder , cancer , prostate cancer , context (archaeology) , oncology , urology , staining , biology , paleontology
Prostatic adenocarcinoma and urothelial carcinoma of the urinary bladder are common cancers in men. High grade forms of these tumors may present ambiguous morphologic features that do not permit a definite diagnosis. This distinction between the two tumors has significant staging and therapeutic implications. Hence, an accurate diagnosis is essential for optimal patient care. p63 is a new marker which can be used in this context. It is expressed in most of the urothelial carcinomas and negative in majority of prostatic adenocarcinomas.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here